Synthesis and In Vivo Evaluation of Pyrazolopyridine and Pyridopyrazolopyrimidine Derivatives as Potent Anticancer Agents Against Ehrlich Ascites Carcinoma-Reference-Cited by-同舟云学术

Synthesis and In Vivo Evaluation of Pyrazolopyridine and Pyridopyrazolopyrimidine Derivatives as Potent Anticancer Agents Against Ehrlich Ascites Carcinoma

Published:2023-09-26 Issue:4 Volume:13 Page:2385-2399
ISSN:2191-1630
Container-title:BioNanoScience
language:en
Short-container-title:BioNanoSci.

Author:

Abo-Neima Sahar E.^ORCID,El-Sheekh Mostafa M.,Keshk Reda M.

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Bioengineering

Link

https://link.springer.com/content/pdf/10.1007/s12668-023-01199-7.pdf

Reference51 articles.

1. Abo-Neima, S., Ismail, A., & Motaweh, H. (2021). Treatment of cancer by radiotherapy and nanoparticles coupled with methotrexate. Iranian Journal of Medical Physics, 18(232-246). https://doi.org/10.22038/ijmp.2020.47108.1747

2. Lichota, A., & Gwozdzinski, K. (2018). Anticancer activity of natural compounds from plant and marine environment. International Journal of Molecular Science, 19(11), 3533. https://doi.org/10.3390/ijms19113533

3. Aboneima, S., Ahmed, A. A., El-Sheekh, M. M., & Makhlof, E. M. (2023). Polycladia myrica-based delivery of selenium nanoparticles in combination with radiotherapy induces potent in vitro antiviral and in vivo anticancer activities against Ehrlich ascites tumor. Frontiers in Molecular Biosciences, 1–15. https://doi.org/10.3389/fmolb.2023.1120422

4. Spiros, H. A., Kiriaki, C., Emmanuel, S., Paraskevi, K., et al. (2022). How the physicochemical properties of manufactured nanomaterials affect their performance in dispersion and their applications in biomedicine. Nanomaterials, 12, 552. https://doi.org/10.3390/nano12030552

5. Srinivasan, M., Rajabi, M., & Mousa, S. A. (2015). Multifunctional nanomaterials and their applications in drug delivery and cancer therapy. Nanomaterials, 5(4), 1690–1703. https://doi.org/10.3390/nano5041690